Re: QSAR - Informatics-Outsourcing

From: David Livingstone <davel>
Date: Tue, 7 Jan 2003 16:29:08 +0100


Hi All,

I must have missed this question when it first appeared or perhaps I didn't see the significance.

> Dear Parthiban:
>
> In my view, outsourcing the informatics and data analysis of a
> pharmaceutical company is very risky, and I would advice against it.

I have to disagree with this.  Mind you, I earn my living from outsourcing so I guess I would, wouldn't I ?

> This for several reasons. (1) The data relating to the development of
> a new drug are very sensitive and should not be allowed to go in
> anybody elses computer, especially not in organized form, i.e.,data
> bases. (2) The results of the analysis of such data are even more
> sensitive and valuable, and should definitely not be seen by
> outsiders.

But these are both amply covered by standard confidentiality agreements.

>(3) The quality of informatics and data analysis depends
> very much on the motivation of the persons actually doing the work.
> Sufficient knowledge and motivation is very difficult or impossible to
> get outside the walls of the pharma company.

Au contraire, it is easy to find the knowledge and motivation if you go to the right person.  I might add that it is often useful to have a fresh pair of eyes look at the problem, to say nothing of new techniques or fresh approaches.

I would like to think that some of my customers agree !

>
> Outsourcing can be done of routine tasks requiring moderate security,
> i.e., payroll and the like. Research and development data of a
> pharmaceutical company are their most valuable asset, and their
> organization and analysis should not be left to others.

I agree that a company needs people on their payroll who understand what is done or needs to be done, but help in R&D is no different to any other kind of help.

Best wishes and Happy New Year,

                        Dave.

>
> With the best regards // Svante Wold, Umea University and Umetrics
> Group.
>     ----- Original Message -----
> From: Parthi
> To: qsar_society~~accelrys.com
> Sent: Thursday, January 02, 2003 7:02 AM
> Subject: QSAR - Informatics-Outsourcing
>
> Dear Colleagues:
> The trend in drug discovery, including the information technology
> area, is to want and get things done faster, more reliably, and less
> expensively, which today means to outsource it. In this scenario, what
> exactly do the pharma and biotech companies are looking for in
> specialised informatics companies for outsourcing. I would appreciate
> your thoughts. Is it client-centric databases or some software
> services or development of client-centric specialised tools. If you
> have something particular I will be happy to contact you to have
> further discussion. Thanks in advance for your replies. I will
> summarise all your replies. Thanks and Regards
>  - Parthiban S
>
> -----------------------------------------------------------
> Do the Informatics companies really have market, if so, whatare the
> key areas that a start-up informatics company should concentrate?
> -------------------------------------------------------------
>
>
> Do you Yahoo!?
> Yahoo! Mail Plus - Powerful. Affordable. Sign up now

------------------------------------------------------------------
D.J. Livingstone                ChemQuest
                      Delamere House, 1 Royal Crescent,
                      Sandown. Isle of Wight UK PO36 8LZ

Phone & Fax: +44 (0)1983 401793
e-mail davel+/-chmqst.demon.co.uk   http://www.chmqst.demon.co.uk
------------------------------------------------------------------
Received on 2003-01-07 - 12:11 GMT

This archive was generated by hypermail 2.2.0 : 2005-11-24 - 10:21 GMT